ABOUT QWYN AI

Built by quality experts, powered by AI

Qwyn AI was founded on a simple belief: the best deviation investigations happen when deep domain expertise meets intelligent automation. Our team combines decades of pharmaceutical quality experience with enterprise-grade AI engineering to build the tools that quality teams actually need.

Our Mission

To eliminate repeat deviations and investigation backlogs in Life Sciences by giving every quality team an AI co-investigator that thinks like their best senior expert—but never sleeps, never forgets, and never cuts corners.

OUR VALUES

What drives us

These principles shape every product decision, every customer interaction, and every line of code we write.

Domain Obsession

We live and breathe Life Sciences quality. Every feature is informed by real investigators, real deviations, and real regulatory demands.

Trust by Design

Regulated environments demand more than good intentions. We engineer compliance, auditability, and transparency into every layer of the platform.

Human + AI

AI should amplify expertise, not replace it. Qwyn is a co-investigator that works alongside your team—keeping humans in the loop on every decision.

Relentless Improvement

We ship fast, measure obsessively, and iterate relentlessly. Every investigation our customers run makes Qwyn smarter and more effective.

LEADERSHIP

The team behind Qwyn

Domain experts and enterprise technologists united by a mission to transform pharmaceutical quality.

Adam Martin

Co-Founder & CEO

Serial entrepreneur and enterprise SaaS veteran building AI tools that help pharmaceutical quality teams investigate deviations faster and reduce drug shortages.

John Coffman

Co-Founder & CTO

20-year pharmaceutical manufacturing and quality leader formerly with Lilly, Elanco, and Thermo Fisher. Co-built Qwyn AI to automate deviation investigation workflows.